Stereotaxis Inc (AMEX: STXS) on Friday, soared 2.49% from the previous trading day, before settling in for the closing price of $2.81. Within the past 52 weeks, STXS’s price has moved between $1.54 and $3.05.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Healthcare Sector giant saw their annual sales slid by -25.52% over the last five years. The company achieved an average annual earnings per share of 21.67%. With a float of $74.09 million, this company’s outstanding shares have now reached $86.00 million.
Stereotaxis Inc (STXS) Breakdown of a Key Holders of the stock
Observing investor behavior towards Medical Instruments & Supplies industry stocks is more important than anything else. The insider ownership of Stereotaxis Inc is 18.27%, while institutional ownership is 46.26%. The most recent insider transaction that took place on Mar 10 ’25, was worth 68,780. In this transaction Director of this company bought 38,000 shares at a rate of $1.81, taking the stock ownership to the 87,299 shares. Before that another transaction happened on Mar 06 ’25, when Company’s Director bought 23,299 for $1.81, making the entire transaction worth $42,171. This insider now owns 49,066 shares in total.
Stereotaxis Inc (STXS) Recent Fiscal highlights
As on 9/30/2024, Multinational firm has announced its last quarter scores, in which it reported -0.08 earnings per share (EPS) for the period falling under the consensus outlook (set at -0.05) by -0.03. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.05 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 21.67% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 48.91% during the next five years compared to -25.52% drop over the previous five years of trading.
Stereotaxis Inc (AMEX: STXS) Trading Performance Indicators
Stereotaxis Inc (STXS) is currently performing well based on its current performance indicators. A quick ratio of 0.59 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 8.21.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.28, a number that is poised to hit -0.06 in the next quarter and is forecasted to reach -0.18 in one year’s time.
Technical Analysis of Stereotaxis Inc (STXS)
Analysing the last 5-days average volume posted by the [Stereotaxis Inc, STXS], we can find that recorded value of 0.29 million was lower than the volume posted last year of 0.45 million. As of the previous 9 days, the stock’s Stochastic %D was 40.99%.
During the past 100 days, Stereotaxis Inc’s (STXS) raw stochastic average was set at 88.53%, which indicates a significant increase from 66.54% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.15 in the past 14 days, which was higher than the 0.12 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $2.42, while its 200-day Moving Average is $2.19. Now, the first resistance to watch is $2.93. This is followed by the second major resistance level at $2.97. The third major resistance level sits at $3.03. If the price goes on to break the first support level at $2.83, it is likely to go to the next support level at $2.77. Now, if the price goes above the second support level, the third support stands at $2.73.
Stereotaxis Inc (AMEX: STXS) Key Stats
Market capitalization of the company is 261.08 million based on 90,654K outstanding shares. Right now, sales total 26,920 K and income totals -24,050 K. The company made 8,800 K in profit during its latest quarter, and -3,830 K in sales during its previous quarter.
